In an interview with 'Self,' influencer Remi Bader opened up about her difficult experience with the weight loss drug Ozempic when she first embarked on her weight loss journey.

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.

Fact checked by Nick Blackmer Remi Bader rose to fame as a plus-sized, body-positive influencer known for sharing deeply ...

Adults who undergo Roux-en-Y gastric bypass are more likely to lose 50% or more of their excess body weight than those who ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

During the surgery, Ren-Fielding explained ... when it comes to weight loss. “It’s like gastric bypass plus, or sleeve gastrectomy plus,” she said. However, she said it does have some ...

What is SADI? The new weight loss surgery Remi Bader had that removes 80% of the stomach - Single Anastomosis Duodenal Switch is a procedure designed for people with class three obesity ...

Chrissy Metz opened up about the secrets behind her 100-pound weight loss while addressing Ozempic and gastric bypass surgery ...

Chrissy Metz has struggled with weight and emotional eating for most of her life. Life & Style breaks down her most ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...